Pharmaceutical News and Articles

Could Certain Genes Help You Slim Down?

The key to weight loss could come down to a combination of 14 skinny genes, a recent study says. People with these genes dropped twice as much weight through re

Government Crackdowns Can Cripple Bogus Stem Cell 'Cures' Industry

Hucksters offering bogus stem cell treatments can be deterred through government action, a new study says. About 60 of direct-to-consumer advertising from fly-b

All Those Head Spins By Breakdancers Could Be Harming Them

This year, breakdancing joined the ranks of Olympic-caliber sports, with Japan s B-girl Ami Yuasa and Canada s B-boy Phil Wizard taking home the gold.Now doctor

IV Fluid Plant in Florida Remains Functional After Milton

Facing a nationwide shortage of vital IV fluids after Hurricane Helene knocked out a North Carolina production plant, officials heaved a sigh of relief at the n

Boehringer Receives U.S. FDA Breakthrough Therapy Designation and Initiates Two Phase III trials in MASH for Survodutide

Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for survodutide (BI 456906),

Patients With Rheumatoid Arthritis Frequently Have Persisting Pain

Patients with rheumatoid arthritis (RA) undergoing standard-of-care treatment frequently have persisting pain, according to a study published online Sept. 30 in

FDA Approves Itovebi (inavolisib) for the Combination Treatment of Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation

Hematologic Cancer Develops in Some Patients Receiving Eli-Cel

Hematologic cancer develops in some patients receiving lentiviral elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy, according to

1999 to 2018 Saw Decrease in Intake of Vitamin A, Vitamin C, Iron in Women

From 1999 to 2018, there was a decrease in vitamin A, vitamin C, and iron intake among pregnant and nonpregnant women, according to a study published online Oct

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients

Biogen Inc. (Nasdaq BIIB) Biogen announced today that felzartamab, an investigational anti-CD38 monoclonal antibody, has received Breakthrough Therapy Designati